CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biotoxtech Co Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biotoxtech Co Ltd (Parent)
Ochang Science Industrial Complex
686-2, Yangcheong-Ri, Ochang-Eup
Phone: +82 432107777p:+82 432107777 CHEONGJU, 28115  South Korea Fax: +82 432107778f:+82 432107778

Business Summary
Biotoxtech Co., Ltd. is a Korea-based company engaged in the research of non-clinical evaluation business. The Company provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201612/31/2016Yes----

Industries
SIC Code Description
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Jong GuKang 66 3/21/2008 1/1/2000
Internal Auditor Myeong CheolShin 40 3/21/2008 3/21/2008
Director Yong BaePark 48 3/21/2008 3/21/2008
Director Seong JinBaek 43 3/27/2009 3/27/2009
Director Dong YilKim 45 3/27/2009 3/27/2009

General Information
Number of Employees: 180 (As of 9/30/2013)
Outstanding Shares: 15,927,512 (As of 6/8/2023)
Shareholders: 2,275
Fax Number: +82 432107778


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023